Kimia Biosciences Ltd gets permission for Bemopedoic acid bulk drug

Kimia Biosciences Ltd has been granted permission to manufacture and marketing of Bemopedoic acid Bulk Drug under New Drug and Clincial Trials Rules, 2019, under Drug & Cosmetics Acts, 1940 for manufacture and market of Bempedoic acid Bulk Drug.

The permission has been granted by Directorate General of Health Services Central Drugs Standard Control Organisation (New Drug Division) vide letter dated 17.05.2022.

Shares of Kimia Biosciences Ltd was last trading in BSE at Rs. 38.80 as compared to the previous close of Rs. 38.30. The total number of shares traded during the day was 524 in over 8 trades.

The stock hit an intraday high of Rs. 38.90 and intraday low of 36.70. The net turnover during the day was Rs. 20305.00.

Source : Equity Bulls

Keywords

KimiaBiosciences INE285U01025 Permission Bemopedoicacid BulkDrug